Company / Working Capital
Upstream Bio, Inc. Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$338.3M
FY2025
5-year range
$110.5M / $468.4M
FY2023-FY2025
Trend
-27.8%
vs FY2024
Sector context
#127 of 213
Health Care
What the data says
At $338M, Upstream Bio, Inc.'s working capital ranks #127 of 213 in the Health Care sector. Improved from $110M to $338M over the past 2 years.
Based on SEC 10-K filings.
$338M in FY2025.
Improved from $110M to $338M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#127 of 213 in Health CareTop 60% of 213This company $338.3M Sector average $934.6M
▼
-63.8% below sector average
Key checks
Key Insights
- In FY2025, working capital decreased 27.8% year-over-year.
- Ranks #127 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $338.3M | -27.8% |
| FY2024 | $468.4M | +324.0% |
| FY2023 | $110.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026